Clinical Research Directory
Browse clinical research sites, groups, and studies.
Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors
Sponsor: University of Chicago
Summary
The goal of the proposed study is to compare the efficacy of behavioral treatment (BT) to memantine, a psychopharmacological agent, for BFRBs. 28 subjects with trichotillomania (TTM) or skin picking disorder (SPD) will receive 8 weeks of memantine treatment, followed by 8 weeks of comprehensive behavioral therapy (ComB) treatment. The hypothesis to be tested is that behavioral therapy will be associated with superior clinical outcomes as compared to memantine. A second hypothesis is that both memantine and behavioral therapy will demonstrate improvement from baseline to the respective posttreatment assessment.
Official title: Single-Group Crossover Trial Comparing Behavioral Treatment to Memantine in Body Focused Repetitive Behaviors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
26
Start Date
2023-08-02
Completion Date
2026-06
Last Updated
2025-12-03
Healthy Volunteers
No
Interventions
Memantine
Cognition-enhancing medication
ComB Behavioral Therapy
Therapy for BFRBs
Locations (1)
University of Chicago Medical Center
Chicago, Illinois, United States